Insider · CIK 0001502240

OrbiMed Capital GP IV LLC

CIK 0001502240 Name as filed on the most recent filing

Filed as OrbiMed Capital GP IV LLC (55)

195 transaction lines · from 55 filings · filed 2010-10-04 to 2024-07-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2014-08-14 S, Open-market sale Intercept Pharmaceuticals IncICPT 959,800, disposed Open Form 4 filing 0000947871-14-000535
2014-08-14 S, Open-market sale Intercept Pharmaceuticals IncICPT 528,501, disposed Open Form 4 filing 0000947871-14-000535
2014-08-14 S, Open-market sale Intercept Pharmaceuticals IncICPT 515,426, disposed Open Form 4 filing 0000947871-14-000535
2014-08-14 S, Open-market sale Intercept Pharmaceuticals IncICPT 362,394, disposed Open Form 4 filing 0000947871-14-000535
2014-08-14 S, Open-market sale Intercept Pharmaceuticals IncICPT 332,806, disposed Open Form 4 filing 0000947871-14-000535
2014-08-14 S, Open-market sale Intercept Pharmaceuticals IncICPT 160,772, disposed Open Form 4 filing 0000947871-14-000535
2014-08-14 S, Open-market sale Intercept Pharmaceuticals IncICPT 107,844, disposed Open Form 4 filing 0000947871-14-000535
2014-08-14 S, Open-market sale Intercept Pharmaceuticals IncICPT 29,861, disposed Open Form 4 filing 0000947871-14-000535
2014-07-01 S, Open-market sale Mirati Therapeutics, Inc.MRTX 100,200, disposed Open Form 4 filing 0000947871-14-000434
2014-06-30 S, Open-market sale Mirati Therapeutics, Inc.MRTX 2 lines 288,299, disposed Open Form 4 filing 0000947871-14-000434
2014-06-27 S, Open-market sale Mirati Therapeutics, Inc.MRTX 2 lines 1,936,730, disposed Open Form 4 filing 0000947871-14-000434
2014-04-09 S, Open-market sale Intercept Pharmaceuticals IncICPT 26,017,600, disposed Open Form 4 filing 0001140361-14-016536
2013-11-20 P, Open-market purchase Relypsa IncRLYP 7,834,112, acquired Open Form 4 filing 0000947871-13-000751
2013-10-29 P, Open-market purchase Mirati Therapeutics, Inc.MRTX 2,187,500, acquired Open Form 4 filing 0000947871-13-000728
2013-10-21 S, Open-market sale Intercept Pharmaceuticals IncICPT 2,505,500, disposed Open Form 4 filing 0001140361-13-039408
2013-10-15 S, Open-market sale Intercept Pharmaceuticals IncICPT 23,536,563, disposed Open Form 4 filing 0001140361-13-039006
2013-01-30 P, Open-market purchase Anthera Pharmaceuticals IncANTH 3,762,000, acquired Open Form 4 filing 0000947871-13-000064
2013-01-25 P, Open-market purchase Anthera Pharmaceuticals IncANTH 1,142,481, acquired Open Form 4 filing 0000947871-13-000047
2012-10-16 P, Open-market purchase Intercept Pharmaceuticals IncICPT 5,000,010, acquired Open Form 4 filing 0001140361-12-043888
2012-06-29 S, Open-market sale Anthera Pharmaceuticals IncANTH 942,071, disposed Open Form 4 filing 0000947871-12-000526
2012-03-22 S, Open-market sale Anthera Pharmaceuticals IncANTH 3,140,131, disposed Open Form 4 filing 0000947871-12-000331
2012-03-21 S, Open-market sale Anthera Pharmaceuticals IncANTH 358,313, disposed Open Form 4 filing 0000947871-12-000331
2012-03-20 S, Open-market sale Anthera Pharmaceuticals IncANTH 338,638, disposed Open Form 4 filing 0000947871-12-000331
2011-12-13 S, Open-market sale Anthera Pharmaceuticals IncANTH 105,300, disposed Open Form 4 filing 0000947871-11-001001
2011-12-09 S, Open-market sale Anthera Pharmaceuticals IncANTH 270,000, disposed Open Form 4 filing 0000947871-11-001001
2011-11-18 S, Open-market sale Anthera Pharmaceuticals IncANTH 19,500, disposed Open Form 4 filing 0000947871-11-000919
2011-11-17 S, Open-market sale Anthera Pharmaceuticals IncANTH 160,080, disposed Open Form 4 filing 0000947871-11-000919
2011-11-16 S, Open-market sale Anthera Pharmaceuticals IncANTH 171,750, disposed Open Form 4 filing 0000947871-11-000919
2011-11-15 S, Open-market sale Anthera Pharmaceuticals IncANTH 346,500, disposed Open Form 4 filing 0000947871-11-000917
2011-11-14 S, Open-market sale Anthera Pharmaceuticals IncANTH 34,750, disposed Open Form 4 filing 0000947871-11-000917
2011-11-11 S, Open-market sale Anthera Pharmaceuticals IncANTH 35,700, disposed Open Form 4 filing 0000947871-11-000917
2011-06-10 S, Open-market sale Anthera Pharmaceuticals IncANTH 245,400, disposed Open Form 4 filing 0000947871-11-000586
2011-06-09 S, Open-market sale Anthera Pharmaceuticals IncANTH 300,070, disposed Open Form 4 filing 0000947871-11-000586
2011-06-08 S, Open-market sale Anthera Pharmaceuticals IncANTH 264,660, disposed Open Form 4 filing 0000947871-11-000586
2011-05-26 S, Open-market sale Anthera Pharmaceuticals IncANTH 291,726, disposed Open Form 4 filing 0000947871-11-000533
2011-05-25 S, Open-market sale Anthera Pharmaceuticals IncANTH 41,520, disposed Open Form 4 filing 0000947871-11-000533
2011-05-18 S, Open-market sale Anthera Pharmaceuticals IncANTH 556,752, disposed Open Form 4 filing 0000947871-11-000553
2011-05-17 S, Open-market sale Anthera Pharmaceuticals IncANTH 832,000, disposed Open Form 4 filing 0000947871-11-000553
2011-05-16 S, Open-market sale Anthera Pharmaceuticals IncANTH 86,400, disposed Open Form 4 filing 0000947871-11-000553
2011-05-11 S, Open-market sale Anthera Pharmaceuticals IncANTH 93,860, disposed Open Form 4 filing 0000947871-11-000552
2011-05-10 S, Open-market sale Anthera Pharmaceuticals IncANTH 769,272, disposed Open Form 4 filing 0000947871-11-000552
2011-05-09 S, Open-market sale Anthera Pharmaceuticals IncANTH 72,600, disposed Open Form 4 filing 0000947871-11-000552
2010-09-30 P, Open-market purchase Anthera Pharmaceuticals IncANTH 81,192, acquired Open Form 4 filing 0001140361-10-039795

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. OrbiMed Capital GP IV LLC, insider transactions. Retrieved 2026-08-27 from https://ebomi.com/insider/0001502240

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.